Navigating the Diagnostic Process: Testing and Imaging

The path to diagnosing surfactant protein C (SP-C) deficiency has changed significantly in recent years. While doctors once relied heavily on surgery to get answers, a modern key part of diagnosis is a non-invasive look at your DNA. Because the symptoms of this condition overlap with many other lung diseases, reaching a definitive diagnosis requires a combination of genetic testing and detailed imaging of the lungs ^[1][2].

Genetic Sequencing: A Key Piece of the Puzzle

An important step in the diagnostic journey is genetic sequencing of the SFTPC gene. This test looks for a “spelling error” in the genetic code that provides instructions for making surfactant protein C ^[3].

• Targeted Panels: Doctors often order a multigene panel ^[1]. This is because SP-C deficiency can look exactly like other surfactant disorders (such as ABCA3 or SFTPB deficiency). Testing for multiple genes at once helps ensure a faster and more accurate answer, though a negative panel does not definitively exclude disease ^[2].
• Zygosity: In your report, you will likely see the word heterozygous. This means the mutation was found on only one of the two copies of the SFTPC gene, which is typical for this condition ^[2][4].
• Variant Classification: Labs label findings as Pathogenic (known to cause disease), Likely Pathogenic (highly likely to cause disease), or Variant of Uncertain Significance (VUS) ^[5]. A VUS means the lab found a change, but they don’t yet have enough evidence to be sure it causes health problems. A VUS must not be treated as diagnostic or used to alter treatment. These may be reclassified later as more research becomes available ^[5].

Parental Testing

Because this condition can be inherited from a parent or happen spontaneously (de novo), doctors strongly recommend testing both biological parents ^[3]. Finding the mutation in a parent who has no symptoms is common because the gene has reduced penetrance—meaning not everyone with the mutation will get sick ^[4][6]. Parent testing is most actionable when a pathogenic or likely pathogenic familial variant has been identified, and should ideally be arranged through a genetics professional.

Imaging the Lungs: High-Resolution CT (HRCT)

While a standard X-ray often looks blurry or “busy” in children with this condition, a High-Resolution Computed Tomography (HRCT) scan provides high-resolution cross-sectional images of the lung tissue ^[7]. In SP-C deficiency, radiologists look for several key patterns:

• Ground-Glass Opacities (GGO): This looks like a hazy, clouded area on the scan, similar to looking through a fogged-up window. It represents inflammation or fluid in the tiny air sacs, but has multiple possible causes ^[8][9].
• Cysts: These are small, air-filled holes in the lung tissue. They often appear as the disease progresses ^[10][11].
• Reticulation: This refers to a “net-like” pattern of lines on the scan, which often indicates fibrosis (scarring) ^[8][10].

The decision to image a child considers radiation exposure, possible sedation, and whether the result will change management; CT patterns generally cannot reliably distinguish SFTPC disease from every other surfactant disorder.

The Role of BAL and Lung Biopsy

In the past, a lung biopsy (surgically removing a small piece of lung tissue) was the only way to diagnose this condition. Today, invasive tests are generally reserved for specific situations, as biopsy carries respiratory and procedural risks ^[12]:

1. When genetics are inconclusive: If genetic testing is negative or only finds a VUS, a biopsy can help identify the physical pattern of the disease ^[2].
2. To rule out other causes: A Bronchoalveolar Lavage (BAL)—an invasive sampling procedure—involves washing a small area of the lung with salt water and collecting the fluid. This is primarily used to check for infections or unusual bleeding in the lungs (alveolar hemorrhage) ^[13][14].
3. Immediate Management: If a patient is extremely ill and genetic results will take weeks to return, a biopsy may be done to guide immediate treatment ^[12].

A biopsy for SP-C deficiency might show patterns called NSIP (Non-Specific Interstitial Pneumonia) or DIP (Desquamative Interstitial Pneumonia), which describe how the cells are arranged under a microscope, but these are not specific to the disease ^[10][15].

Checklist: Reviewing Your Reports

When you receive copies of your medical reports, check for these specific details to ensure the evaluation is complete:

Confirming the diagnosis through these steps allows your care team to move from “searching for answers” to “building a management plan” ^[17].